Invesaro

Stocks Comparison

Petmed Express vs 111: revenue, profit, margins and growth compared

Petmed Express brought in $179M of revenue in fiscal 2026, 111 $1.8B in fiscal 2025. Revenue changed by -21.1% at Petmed Express and -9.0% at 111 on the year before, so 111 grew faster. Petmed Express kept -32.0% of its revenue as net profit, 111 -0.5%. Free cash flow was -$33M at Petmed Express and $16.4M at 111.

Side by side, latest fiscal year

PETSYI
Fiscal year endedFY2026 (March 31, 2026)FY2025 (December 31, 2025)
Revenue$179M$1.8B
Revenue growth-21.1%-9.0%
Net income-$57.3M-$9.5M
Net margin-32.0%-0.5%
Free cash flow-$33M$16.4M
Free cash flow margin-18.4%0.9%
Earnings per share (diluted)-$2.74-$0.05
Cash$21.4M$73.1M
Debtn/an/a
Price to earningsn/an/a
Market value$33.2M$31.7M
Dividend yieldn/an/a
Rank by revenue in sector#79 of 125 · Consumer staples#51 of 125 · Consumer staples

Over the years

Revenue
PETS FY2019: $283.4MPETS FY2020: $284.1MPETS FY2021: $303.6MPETS FY2022: $272.3MPETS FY2023: $256.6MPETS FY2024: $281.1MPETS FY2025: $227MPETS FY2026: $179MYI FY2018: $259.8MYI FY2019: $567.7MYI FY2020: $1.3BYI FY2021: $1.9BYI FY2022: $2BYI FY2023: $2.1BYI FY2024: $2BYI FY2025: $1.8BFY18FY19FY20FY21FY22FY23FY24FY25FY26
PETS $179MYI $1.8B
Net income
PETS FY2019: $37.7MPETS FY2020: $25.9MPETS FY2021: $23.9MPETS FY2022: $18.7MPETS FY2023: $5.1MPETS FY2024: -$7.5MPETS FY2025: -$6.3MPETS FY2026: -$57.3MYI FY2018: -$55.3MYI FY2019: -$71.8MYI FY2020: -$70MYI FY2021: -$105.1MYI FY2022: -$60.4MYI FY2023: -$55.3MYI FY2024: -$8.9MYI FY2025: -$9.5MFY18FY19FY20FY21FY22FY23FY24FY25FY26
PETS -$57.3MYI -$9.5M
Net margin
PETS FY2019: 13.3%PETS FY2020: 9.1%PETS FY2021: 7.9%PETS FY2022: 6.9%PETS FY2023: 2.0%PETS FY2024: -2.7%PETS FY2025: -2.8%PETS FY2026: -32.0%YI FY2018: -21.3%YI FY2019: -12.6%YI FY2020: -5.6%YI FY2021: -5.4%YI FY2022: -3.1%YI FY2023: -2.6%YI FY2024: -0.4%YI FY2025: -0.5%FY18FY19FY20FY21FY22FY23FY24FY25FY26
PETS -32.0%YI -0.5%
Revenue growth
PETS FY2020: +0.2%PETS FY2021: +6.8%PETS FY2022: -10.3%PETS FY2023: -5.8%PETS FY2024: +9.5%PETS FY2025: -19.2%PETS FY2026: -21.1%YI FY2019: +118.5%YI FY2020: +121.5%YI FY2021: +55.1%YI FY2022: +0.5%YI FY2023: +7.4%YI FY2024: -6.3%YI FY2025: -9.0%FY19FY20FY21FY22FY23FY24FY25FY26
PETS -21.1%YI -9.0%
Free cash flow
PETS FY2019: $44.5MPETS FY2020: $36.5MPETS FY2021: $37.6MPETS FY2022: $16.7MPETS FY2023: $22.5MPETS FY2024: -$194KPETS FY2025: -$395KPETS FY2026: -$33MYI FY2018: -$52MYI FY2019: -$76.5MYI FY2020: -$21.8MYI FY2021: -$117.9MYI FY2022: -$7.9MYI FY2023: -$64.4MYI FY2024: $34MYI FY2025: $16.4MFY18FY19FY20FY21FY22FY23FY24FY25FY26
PETS -$33MYI $16.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Petmed Express and 111

Which is bigger by revenue, Petmed Express or 111?

111 is bigger by revenue: $1.8B in fiscal 2025, against $179M for Petmed Express in fiscal 2026.

Which keeps more of its revenue as profit, Petmed Express or 111?

Petmed Express had a net margin of -32.0% in fiscal 2026; 111 had -0.5% in fiscal 2025.

Which grew revenue faster, Petmed Express or 111?

In their latest fiscal years revenue changed by -21.1% at Petmed Express and -9.0% at 111.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies